• Erastin and the Next Frontier of Ferroptosis

  2026-09-01

  Erastin is more than a standard ferroptosis inducer: it is a mechanistic probe for connecting RAS/BRAF-associated redox vulnerability with the plasma-membrane events that determine ferroptotic execution and tumor immune visibility.

• DAT PET Tracks Dopamine Neuron Maturation in PD

  2026-09-01

  Goggi et al. showed that dopamine transporter PET can noninvasively monitor the survival, maturation, and presynaptic integration of transplanted human embryonic stem cell-derived dopaminergic neurons in a rat model of Parkinson’s disease. The study is important because DAT imaging correlated with tyrosine hydroxylase differentiation more reliably than functional dopamine-release imaging, providing a practical longitudinal endpoint for cell-therapy development.

• AZD3463: ALK/IGF1R Workflow Guide

  2026-08-31

  Build genotype-aware neuroblastoma assays around AZD3463, an ALK/IGF1R inhibitor that connects target engagement with PI3K/AKT/mTOR, apoptosis, autophagy, and combination-response readouts. This practical guide distinguishes evidence-backed conditions from optimization steps, helping researchers improve dosing, pathway validation, and translational interpretation.

• Flubendazole Workflows for Autophagy Research

  2026-08-30

  Flubendazole provides a DMSO-soluble route to study autophagy alongside the glutamine–GDH metabolic axis implicated in hepatic stellate-cell activation. This practical guide connects flux assays, metabolic readouts, cancer biology research, and troubleshooting without treating exploratory findings as antifibrotic evidence.

• Tomivosertib Suppresses Ectopic Activity in Human DRG

  2026-08-29

  A 2024 Brain study tested MNK inhibition directly in cultured human dorsal root ganglion neurons obtained from patients with radiculopathy. Tomivosertib rapidly and reversibly reduced spontaneous neuronal activity while altering electrophysiological properties and suppressing eIF4E phosphorylation, providing translational support for MNK inhibitors in neuropathic pain research.

• DMXAA (Vadimezan): From Vascular Disruption to STING

  2026-08-29

  Explore how DMXAA (Vadimezan) connects tumor vascular disruption with DNA damage and STING-focused nanomedicine. This guide translates the latest nanorod study into practical assay and cancer biology research decisions.

• Caspase-3 Colorimetric Assay Kit: Practical Guide

  2026-08-28

  The Caspase-3 Colorimetric Assay Kit measures DEVD-dependent caspase-3 activity in biological sample lysates through release of p-nitroaniline and absorbance detection. It is appropriate for comparative apoptosis assays and caspase activity measurement, but the signal should not be treated as exclusive proof of caspase-3 activation without suitable controls or orthogonal validation.

• SAG Protects Frataxin-Deficient Astrocytes

  2026-08-28

  Vicente-Acosta and colleagues show that frataxin depletion makes cultured human astrocytes dysfunctional, metabolically altered, and neurotoxic, while chronic Smoothened receptor agonist treatment largely prevents these changes. The work positions Hedgehog pathway modulation as a glia-centered neuroprotective strategy in Friedreich’s ataxia, while leaving important questions about in vivo efficacy, dosage, and disease translation unresolved.

• TAK 491: Reframing AT1 Blockade in Translation

  2026-08-27

  Azilsartan medoxomil monopotassium offers translational researchers a high-affinity AT1 receptor antagonist for connecting receptor pharmacology with durable blood pressure control. This thought-leadership guide explains how to validate washout-resistant antagonism, design fit-for-purpose assays, interpret comparator data, and position TAK 491 in essential hypertension treatment research and cardiovascular disease research.

• Computational Hapten Design for Dual Mushroom Toxin Detectio

  2026-08-27

  The reference study combines molecular similarity analysis, quantum-chemical calculations, and monoclonal antibody development to improve simultaneous recognition of amatoxins and phallotoxins. Its dual-target fluorescent immunochromatographic assay detected both toxin classes at low microgram-per-kilogram levels in mushroom matrices, addressing a major limitation of earlier single-target rapid tests.

• MLN4924 Workflow for NEDD8 Pathway Studies

  2026-08-26

  MLN4924 provides a pharmacological route to dissect NAE activity, cullin-RING ligase signaling, and protein-stability changes in cancer models. This workflow connects pathway validation with radiation- and etoposide-response assays while emphasizing compound handling, controls, and troubleshooting.

• L-Phenylephrine α1A Signaling Workflows

  2026-08-26

  Use L-Phenylephrine as a controlled adrenergic α1A receptor agonist for mechanistic studies spanning cardiomyocyte stress, baroreflex physiology, and neural progenitor assays. This guide translates sex-specific hypertension findings into practical experimental controls, concentration screens, and troubleshooting decisions.

• Caspase-4 Colorimetric Assay Kit Guide

  2026-08-25

  The Caspase-4 Colorimetric Assay Kit measures LEVD-dependent caspase-4 activity through p-nitroaniline release and absorbance detection. This colorimetric caspase assay supports quantitative studies of cytosolic LPS sensing, pyroptosis, inflammasome signaling, and related inflammatory pathways.

• Nuclear PI3P Regulates DNA Mismatch Repair

  2026-08-25

  The reference study identifies nuclear phosphatidylinositol-3-phosphate (PI3P), produced by a Beclin-1/Vps34 complex, as a non-protein regulator of DNA mismatch repair. Its findings connect Vps34 activity to MutS complex assembly, DNA lesion recognition, microsatellite stability, and cellular responses to 6-thioguanine through an autophagy-independent mechanism.

• CFDA SE Cell Tracer Kit: Protocol Guide

  2026-08-24

  The CFDA SE Cell Tracer Kit provides persistent fluorescent labeling for cell proliferation studies, cell lineage tracing, and live-cell tracking workflows. It is appropriate when durable covalent marking is needed, but not for reversible, rapidly cleared, or strictly short-term staining experiments.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page